Blue Earth Diagnostics Receives Positive Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer Post author:Sam Post published:March 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug July 4, 2017 Tax Reform: A War on Life Sciences Innovation December 11, 2017 Safety Issues Force the FDA to Turn Down Amgen, UCB SA's Osteoporosis Drug July 16, 2017